When Maroney joined CVIS, the company had 12 employees. Maroney stayed on as general manager of BSC's San Jose operations and as president of EP Technologies, a division acquired in 1996 that manufactures cardiac electrophysiology products. There he had responsibility for the growth of established markets as well as the development of new technology. The company is in the early clinical feasibility phase for two stent products. Every day critical decisions get made, not just about where the technology goes but how to grow and position a company in new, evolving markets.
Every day means breathing life into a new venture.
Having worked for both small start-ups and large corporations, Maroney can appreciate their differences. That means Maroney often spends his days either drumming up capital or communicating with investors to keep them involved. Soon, Maroney realizes, his role will change again, as it did at the other start-ups. The focus now is intense product development and clinical research. As products are close to being marketed, sales, marketing, and manufacturing issues take on a bigger role.